SLK STRATEGIES for RECOMBINETICS, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Science/Technology SCI
Federal regulation of animals benefiting from gene editing Use of gene edited animals in human food production, disease mitigation
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KOPPERUD | — |
Health Issues HCR
Research dollars allocated for NIH cancer "moon shot" initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KOPPERUD | — |
Budget/Appropriations BUD
Appropriations for increase NIH research on animals, gene editing Appropriations for an increase in research at DARPA Spending of research appropriations at FDA, NIH, DARPA, USDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KOPPERUD | — |
Food Industry (safety, labeling, etc.) FOO
Safety of foods from animals modified through gene editing GRAS status of foods from animals modified through gene editing Labeling of foods from biotech animals
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KOPPERUD | — |
Animals ANI
Prospective regulation of genome editing as targeted reproductive tool in agriculture Federal review and approval of biotech animals generally Care and treatment of biotech animals in research Animal welfare
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN KOPPERUD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.